Zobrazeno 1 - 10
of 886
pro vyhledávání: '"O'Bryan, JP"'
Autor:
Whaby M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Ketavarapu G; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Koide A; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.; Department of Medicine, New York University School of Medicine, New York, NY, USA., Mazzei M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Mintoo M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Glasser E; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Patel U; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA., Nasarre C; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Sale MJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., McCormick F; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Koide S; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA. shohei.koide@nyulangone.org.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA. shohei.koide@nyulangone.org., O'Bryan JP; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA. obryanjo@musc.edu.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. obryanjo@musc.edu.; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA. obryanjo@musc.edu.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. obryanjo@musc.edu.
Publikováno v:
Oncogene [Oncogene] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Whaby M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Nair RS; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA., O'Bryan JP; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA. obryanjo@musc.edu.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. obryanjo@musc.edu.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. obryanjo@musc.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2797, pp. 211-225.
Autor:
Sonawane K, Borse KN, Jefferson M, Damgacioglu H, Carpenter MJ, Pearce JL, Ogretmen B, Paczesny S, O'Bryan JP, Obeid JS, Ford ME, Deshmukh AA
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
Autor:
Ferretti GDS; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Quaas CE; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Bertolini I; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA., Zuccotti A; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Saatci O; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Kashatus JA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, VA, USA., Sharmin S; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, VA, USA., Lu DY; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA., Poli ANR; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA., Quesnelle AF; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Rodriguez-Blanco J; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Darby Children's Research Institute, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA., de Cubas AA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA., Hobbs GA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA., Liu Q; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA., O'Bryan JP; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA., Salvino JM; Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA., Kashatus DF; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia Health System, Charlottesville, VA, USA., Sahin O; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Barnoud T; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA. barnoud@musc.edu.; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA. barnoud@musc.edu.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2024 Jul; Vol. 31 (7), pp. 881-896. Date of Electronic Publication: 2024 May 28.
Autor:
Mintoo M; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, U.S.A., Rajagopalan V; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, U.S.A., O'Bryan JP; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, U.S.A.; Ralph H. Johnson VA Medical Center, Charleston, SC 29401, U.S.A.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2024 Feb 28; Vol. 52 (1), pp. 1-13.
Autor:
Akkapeddi P; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Hattori T; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016.; Dertment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016., Khan I; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29425., Glasser E; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Koide A; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016.; Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016., Ketavarapu G; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Whaby M; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29425., Zuberi M; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29425., Teng KW; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Lefler J; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425., Maso L; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Bang I; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Ostrowski MC; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425., O'Bryan JP; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29425., Koide S; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016.; Dertment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Jul 11; Vol. 120 (28), pp. e2302485120. Date of Electronic Publication: 2023 Jul 03.
Autor:
Siegel JB; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Nasarre P; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Hsu L; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Mukherjee R; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Gormley M; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Richardson B; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Khan I; Department of Cellular and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA., Morningstar JE; Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston SC, USA., Hilliard E; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., O'Bryan JP; Department of Cellular and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.; Ralph H. Johnson VA Medical Center, Charleston, SC, USA., Helke KL; Department of Comparative Medicine, Medical University of South Carolina, Charleston, SC, USA., Spruill L; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA., Dolloff NG; Department of Cellular and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Klauber-DeMore N; Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Publikováno v:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2023; Vol. 38 (3), pp. 287-300.
Autor:
Whaby M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Wallon L; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York, USA., Mazzei M; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Khan I; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA; Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA., Teng KW; Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA., Koide S; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York, USA; Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA. Electronic address: shohei.koide@nyulangone.org., O'Bryan JP; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina, USA; Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA; Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA. Electronic address: obryanjo@musc.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2022 Dec; Vol. 298 (12), pp. 102661. Date of Electronic Publication: 2022 Nov 09.
Autor:
Wallon L; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Khan I; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29401., Teng KW; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Koide A; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016.; Department of Medicine, New York University School of Medicine, New York, NY 10016., Zuberi M; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29401., Li J; Department of Chemistry, New York University, New York, NY 10003., Ketavarapu G; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016., Traaseth NJ; Department of Chemistry, New York University, New York, NY 10003., O'Bryan JP; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425.; Ralph H. Johnson VA Medical Center, Charleston, SC 29401., Koide S; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY 10016.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Oct 25; Vol. 119 (43), pp. e2204481119. Date of Electronic Publication: 2022 Oct 17.
Autor:
Khan I; Department of Pharmacology, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, 60612, USA.; Jesse Brown VA Medical Center, Chicago, IL, 60612, USA.; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, 29425, USA.; Ralph H. Johnson VA Medical Center, Charleston, SC, 29401, USA., Spencer-Smith R; Department of Pharmacology, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, 60612, USA.; Jesse Brown VA Medical Center, Chicago, IL, 60612, USA., O'Bryan JP; Department of Pharmacology, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, 60612, USA. obryanjo@musc.edu.; Jesse Brown VA Medical Center, Chicago, IL, 60612, USA. obryanjo@musc.edu.; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, 29425, USA. obryanjo@musc.edu.; Ralph H. Johnson VA Medical Center, Charleston, SC, 29401, USA. obryanjo@musc.edu.
Publikováno v:
Oncogene [Oncogene] 2019 Apr; Vol. 38 (16), pp. 2984-2993. Date of Electronic Publication: 2018 Dec 20.